Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection

JAMA. 2022 Oct 4;328(13):1348-1350. doi: 10.1001/jama.2022.15336.
No abstract available

Plain language summary

This case series describes the clinical resolution of systemic symptoms and lesions, along with any adverse events, in patients with monkeypox infection who were treated with tecovirimat on a compassionate use basis.

MeSH terms

  • Antiviral Agents* / therapeutic use
  • Benzamides* / therapeutic use
  • Compassionate Use Trials*
  • Humans
  • Isoindoles / therapeutic use
  • Mpox (monkeypox)* / drug therapy
  • Phthalimides* / therapeutic use


  • Antiviral Agents
  • Benzamides
  • Isoindoles
  • Phthalimides
  • tecovirimat